Cargando…

Zoledronic Acid for Periprosthetic Bone Mineral Density Changes in Patients With Osteoporosis After Hip Arthroplasty—An Updated Meta-Analysis of Six Randomized Controlled Trials

Introduction: Periprosthetic bone mineral density (BMD) loss following total hip arthroplasty (THA) may threaten the survival of the implant, especially in patients with osteoporosis. Zoledronic acid (ZA) is the representative of the third generation of bisphosphonates, which were effective in reduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yuan, Xu, Jia-Wen, Li, Ming-Yang, Wu, Li-Min, Zeng, Yi, Shen, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733298/ https://www.ncbi.nlm.nih.gov/pubmed/35004777 http://dx.doi.org/10.3389/fmed.2021.801282

Ejemplares similares

Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty
por: Hsu, Allen Herng Shouh, et al.
Publicado: (2022)

Stro-1-positive BMSCs predict postoperative periprosthetic bone mineral density outcomes in uncemented total hip arthroplasty patients
por: Shen, Yi, et al.
Publicado: (2014)

Modulation and Predictors of Periprosthetic Bone Mineral Density following Total Knee Arthroplasty
por: Mau-Moeller, Anett, et al.
Publicado: (2015)

Subgroup Variations in Bone Mineral Density Response to Zoledronic Acid After Hip Fracture
por: Magaziner, Jay S, et al.
Publicado: (2014)

Short to Midterm Follow-Up of Periprosthetic Bone Mineral Density after Total Hip Arthroplasty with the Ribbed Anatomic Stem
por: Wu, Xiang-Dong, et al.
Publicado: (2019)

Comparison of Denosumab and Zoledronic Acid in Postmenopausal Women With Osteoporosis: Bone Mineral Density (BMD) and Trabecular Bone Score (TBS)
por: Kang, Taewook, et al.
Publicado: (2022)

Efficiency of Zoledronic Acid in Inhibiting Accelerated Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty in Osteoporotic Patients: A Prospective, Cohort Study
por: Fu, Guang‐tao, et al.
Publicado: (2019)

Effect of Zoledronic Acid on the Vertebral Body Bone Mineral Density After Instrumented Intervertebral Fusion in Postmenopausal Women With Osteoporosis
por: Fan, Junjun, et al.
Publicado: (2021)

High periprosthetic bone mineral density measured in immediate postoperative period may not guarantee less periprosthetic bone loss in the proximal femur after cementless total hip arthroplasty – A retrospective study
por: Fu, Guangtao, et al.
Publicado: (2020)

The Importance of Bone Mineral Density in Hip Arthroplasty: Results of a Survey Asking Orthopaedic Surgeons about Their Opinions and Attitudes Concerning Osteoporosis and Hip Arthroplasty
por: Maier, Gerrit Steffen, et al.
Publicado: (2016)

Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Six monthly intravenous zoledronic acid in childhood osteoporosis
por: Munns, CF, et al.
Publicado: (2013)

Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
por: Uehara, Masashi, et al.
Publicado: (2021)

One-Stage Exchange Arthroplasty for Fistulizing Periprosthetic Joint Infection of the Hip: An Effective Strategy
por: Marmor, Simon, et al.
Publicado: (2020)

Bone turnover and periprosthetic bone loss after cementless total hip arthroplasty can be restored by zoledronic acid: a prospective, randomized, open-label, controlled trial
por: Huang, Tsan-Wen, et al.
Publicado: (2017)

Factors Affecting Periprosthetic Bone Loss after Hip Arthroplasty
por: Lee, Se-Won, et al.
Publicado: (2021)

Denosumab might prevent periprosthetic bone loss after total hip and knee arthroplasties: a review
por: Xu, Jianda, et al.
Publicado: (2021)

Low Bone Mineral Density in Hemophiliacs
por: Gebetsberger, Jennifer, et al.
Publicado: (2022)

Baseline bone mineral density and bone turnover in pre-operative hip and knee arthroplasty patients
por: James, S. J., et al.
Publicado: (2014)

Impact of Medication Adherence on Bone Mineral Density and Fracture Risk in Patients With Osteoporosis: A Systematic Review
por: Alahmari, Manea M, et al.
Publicado: (2023)

Prediction of Bone Mineral Density (BMD) Adaptation in Pelvis–Femur Model with Hip Arthroplasties
por: Abdullah, Abdul Halim, et al.
Publicado: (2021)

Treatment of Periprosthetic Femoral Fractures in Hip Arthroplasty
por: Park, Sung Ki, et al.
Publicado: (2011)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
por: Chapurlat, Roland D
Publicado: (2009)

Treatment of Transient Osteoporosis of the Hip with Intravenous Zoledronate - A Case Report -
por: Seok, Hyun, et al.
Publicado: (2011)

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
por: Agarwala, Sanjay, et al.
Publicado: (2019)

Influence of Vitamin K on Bone Mineral Density and Osteoporosis
por: Elshaikh, Abeer O, et al.
Publicado: (2020)

Differences in periprosthetic bone mineral density tendencies with Types 1 and 3C stems in bipolar hemiarthroplasty following hip fracture
por: Moon, Jun-Ki, et al.
Publicado: (2023)

Denosumab versus zoledronate for the treatment of low bone mineral density in male HIV-infected patients
por: Makras, Polyzois, et al.
Publicado: (2021)

Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker
por: Mori, Y., et al.
Publicado: (2018)

Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study
por: Dito, Giorgia, et al.
Publicado: (2023)

Different uptake patterns of (68)Ga-FAPI in aseptic loosening and periprosthetic joint infection of hip arthroplasty: A case series and literature review
por: Wang, Yiqun, et al.
Publicado: (2022)

Periprosthetic tibial bone mineral density changes after total knee arthroplasty: A 7-year follow-up of 86 patients
por: Jaroma, Antti, et al.
Publicado: (2016)

Factors affecting bone mineral density in children and adolescents with secondary osteoporosis
por: Jang, Min Jeong, et al.
Publicado: (2023)

Treatment of Periprosthetic Femoral Fractures Following Hip Arthroplasty
por: Lee, Joong-Myung, et al.
Publicado: (2018)

Bone mineral density of the femoral neck in resurfacing hip arthroplasty: Precision of DXA biased by region of interest and rotation of the hip
por: Penny, Jeannette Østergaard, et al.
Publicado: (2010)

Influence of vitamin D levels on bone mineral density and osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2011)

Associated Factors of Bone Mineral Density and Osteoporosis in Elderly Males
por: Heidari, Behzad, et al.
Publicado: (2016)

Change in Bone Mineral Density in Stroke Patients with Osteoporosis or Osteopenia
por: Lee, Do-Hee, et al.
Publicado: (2022)

Comparison of Femoral Bone Mineral Density Changes around 3 Common Designs of Cementless Stems after Total Hip Arthroplasty—A Retrospective Cohort Study
por: Liu, Yuan, et al.
Publicado: (2022)

Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis
por: Hong, Pan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p6ac7od2q12uu1st4j0fpdc66q